Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck KGaA drops 10 per cent after drug rejection
Merck KGaA drops 10 per cent after drug rejection
Merck KGaA drops 10 per cent after drug rejection
Submitted by
admin
on September 24, 2010 - 9:57am
Source:
FT.com
News Tags:
Merck KGaA
MS
multiple sclerosis
Headline:
Merck KGaA drops 10 per cent after drug rejection
Do Not Allow Advertisers to Use My Personal information
